Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331 von Spigel, D.R., Vicente, D., Ciuleanu, T.E., Gettinger, S., Peters, S., Horn, L., Audigier-Valette, C., Pardo Aranda, N., Juan-Vidal, O., Cheng, Y., Zhang, H., Shi, M., Luft, A., Wolf, J., Antonia, S., Nakagawa, K., Fairchild, J., Baudelet, C., Pandya, D., Doshi, P., Chang, H., Reck, M.

Volltext

PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic... von Blons, H., Oudart, J.-B., Merlio, J.-P., Debieuvre, D., de Fraipont, F., Audigier-Valette, C., Escande, F., Hominal, S., Bringuier, P.‐P., Fraboulet-Moreau, S., Ouafik, L., Moro-Sibilot, D., Lemoine, A., Langlais, A, Missy, P., Morin, F., Souquet, P.-J., Barlesi, F., Cadranel, J., Beau‐Faller, M.

Volltext

Efficacité et tolérance de l’immunothérapie, seule ou en association avec la chimiothérapie, dans le cancer bronchique non à petites cellules (CBNPC) avec mutation BRAF, HER2 ou ME... von Da Cunha, J., Greillier, L., Daniel, C., Pierret, T., Swalduz, A., Curcio, H., Falchero, L., Auliac, J.B., Ricordel, C., Fournel, P., Doubre, H., De Chabot, G., Bernardi, M., Bylicki, O., Paysse, M., Audigier-Valette, C., Decroisette, C., Guisier, F.

Volltext

Omicron variant: A clear and present danger for patients with cancer von Barrière, J., Zalcman, G., Fignon, L., Peiffer-Smadja, N., Audigier-Valette, C., Carles, M.

Volltext

Impact of Continuing First-Line EGFR Tyrosine Kinase Inhibitor Therapy Beyond RECIST Disease Progression in Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer (NSCLC):... von Auliac, J. B., Fournier, C., Audigier Valette, C., Perol, M., Bizieux, A., Vinas, F., Decroisette Phan van Ho, C., Bota Ouchlif, S., Corre, R., Le Garff, G., Fournel, P., Baize, N., Lamy, R., Vergnenegre, A., Arpin, D., Marin, B., Chouaid, C., Gervais, R.

Volltext

Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitors von Heudel, P.E., de Montfort, A., Debieuvre, D., Chouaid, C., Carton, M., Audigier-Valette, C., Filleron, T., Chabaud, S., Stancu, A., Quantin, X., Hiret, S., Bosquet, L., Blay, J.Y.

Volltext

Real-world treatment patterns, clinical practice and outcomes for locally advanced, non resectable, non-small cell lung cancer from the French ESME Lung database von Girard, N., Pérol, M., Simon, G., Audigier Valette, C., Gervais, R., Debieuvre, D., Schott, R., Quantin, X., Coudert, B., Lena, H., Carton, M., Robain, M., Filleron, T., Chouaid, C.

Volltext

EVIDENS: An observational study of nivolumab-treated patients in advanced non-small cell lung cancer (NSCLC) in a real-world setting: Initial results on 1394 patients von Dixmier, A., Debieuvre, D., Raspaud, C., Auliac, J.B., Benoit, N., Bombaron, P., Asselain, B., Dumont, A., Lamoureux, P., Goyard, N., Moro-Sibilot, D., Perol, M., Barlesi, F., Audigier Valette, C.

Volltext

A randomized non-comparative phase II study of anti–PD-L1 ATEZOLIZUMAB or chemotherapy as second-line therapy in patients with small cell lung cancer: Results from the IFCT-1603 tr... von Pujol, J.-L., Greillier, L., Audigier Valette, C., Moro-Sibilot, D., Uwer, L., Hureaux, J., Thiberville, L., Carmier, D., Madelaine, J., Otto, J., Gounant, V., Merle, P., Mourlanette, P., Molinier, O., Renault, P.A., Mazieres, J., Antoine, M., Langlais, A., Morin, F., Souquet, P.-J.

Volltext

Efficacy and safety of nivolumab (nivo) monotherapy versus chemotherapy (chemo) in recurrent small cell lung cancer (SCLC): Results from CheckMate 331 von Reck, M., Vicente, D., Ciuleanu, T., Gettinger, S., Peters, S., Horn, L., Audigier-Valette, C., Pardo, N., Juan-Vidal, O., Cheng, Y., Zhang, H., Shi, M., Wolf, J., Antonia, S.J., Nakagawa, K., Selvaggi, G., Baudelet, C., Chang, H., Spigel, D.R.

Volltext

Health-related quality of life (HRQoL) of non-small cell lung cancer (NSCLC) patients treated with nivolumab in real-life: The EVIDENS study von Pérol, M., Dixmier, A., Barlesi, F., Debieuvre, D., Raspaud, C., Auliac, J.B., Benoit, N., Bombaron, P., Moro-Sibilot, D., Asselain, B., Cotté, F.-E., Lamoureux, P., Karam, N., Ozan, N., Calvet, C., Bryan, B., Allan, V., Audigier Valette, C.

Volltext

Circulating tumor DNA (ctDNA) in advanced non-small cell lung cancer (NSCLC) from HIV-infected patients is associated to shorter overall survival (OS): Results from phase II trial... von Wislez, M., Blons, H., Domblides, C., Barlesi, F., Mazieres, J., Monnet, I., Kiakouama Maleka, L., Quantin, X., Taillade, L., Lena, H., Fraisse, P., Janicot, H., Audigier Valette, C., Amour, E., Langlais, A., Rabbe, N., Cadranel, J., Laurent puig, P., Lavolé, A.

Volltext

Bevacizumab as first-line treatment in advanced non-squamous non-small cell lung cancer (NSCLC) in patients aged over 65 years in France: Final results of the AVANTAGE study von Lionel, F., Perol, D., Souquet, P.-J., Le Caer, H., Dansin, E., Audigier Valette, C., Mouysset, J.-L., Uffredi, M.L., Ionescu-Goga, M., Veerabudun, K., Lelarge, Y., Fabre-Guillevin, E.

Volltext

Efficacy of immune checkpoint inhibitors in lung sarcomatoid carcinoma: Data from a French multicentric cohort von Domblides, C., Monnet, I., Mazieres, J., Barlesi, F., Gounant, V., Baldacci, S., Mennecier, B., Toffart, A.C., Audigier Valette, C., Doucet, L., Giroux-Leprieur, E., Guisier, F., Molinier, O., Perol, M., Pichon, E., Robinet, G., Templement Grangerat, D., Ruppert, A.-M., Wislez, M.

Volltext

Derived neutrophil-to lymphocyte ratio (dNLR) change between baseline and cycle 2 is correlated with benefit during immune checkpoint inhibitors (ICI) in advanced non-small cell lu... von Mezquita, L., Arbour, K., Auclin, E., Saravia, D., Rizvi, H., Hendriks, L., Planchard, D., Park, W., Nadal, E., Ruffinelli Rodriguez, J.C., Ponce, S., Audigier-Valette, C., Marilniello, A.P., Zalcman, G., Majem, M., Schiavone, G., Dingemans, A.-M.C., Lopes, G., Hellmann, M.D., Besse, B.

Volltext

Lurbinectedin in extensive-stage small-cell lung cancer: a brief report of the IFCT-2105 LURBICLIN study von Girard, N., Guisier, F., Swalduz, A., Van Hulst, S., Pichon, E., Lavaud, P., Greillier, L., Tiotiu, A., Madroszyk, A., Bylicki, O., Canellas, A., Belmont, L., Zysman, M., Hauss, P.-A., Godbert, B., Audigier-Valette, C., Lebreton, C., Morin, F., Westeel, V.

Volltext

Maintenance chemotherapy versus follow-up after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): IFCT-12... von Quoix, E., Audigier Valette, C., Lavolé, A., Molinier, O., Westeel, V., Barlesi, F., Le Treut, J., Pichon, E., Dauba, J., Otto, J., Dumont, P., Moreau, L., Madelaine, J., Margery, J., Debieuvre, D., Renault, P.A., Langlais, A., Morin, F., Moro-Sibilot, D., Souquet, P.-J.

Volltext

Prognostic factors in non-small cell lung cancer (NSCLC) patients (pts) with brain metastases (BM) treated with immune checkpoint inhibitors (ICI) von Hendriks, L., Henon, C., Auclin, E., Mezquita, L., Ferrara, R., Audigier Valette, C., Mazieres, J., Lefebvre, C., Le Moulec, S., Duchemann, B., Le Pechoux, C., Botticella, A., Ammari, S., Gazzah, A., Caramella, C., Adam, J., Planchard, D., De Ruysscher, D., Dingemans, A.-M.C., Besse, B.

Volltext

Clinical characteristic and survival outcomes of patients with advanced NSCLC according to KRAS mutational status in the French real-life ESME cohort von Thomas, Q.D., Quantin, X., Lemercier, P., Chouaid, C., Schneider, S., Filleron, T., Remon-Masip, J., Perol, M., Debieuvre, D., Audigier-Valette, C., Justeau, G., Loeb, A., Hiret, S., Clement-Duchene, C., Dansin, E., Stancu, A., Pichon, E., Bosquet, L., Girard, N., Du Rusquec, P.

Volltext

IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer von Molinier, O., Besse, B., Barlesi, F., Audigier-Valette, C., Friard, S., Monnet, I., Jeannin, G., Mazières, J., Cadranel, J., Hureaux, J., Hilgers, W., Quoix, E., Coudert, B., Moro-Sibilot, D., Fauchon, E., Westeel, V., Brun, P., Langlais, A., Morin, F., Souquet, P.J., Girard, N.

Volltext